From €861EUR$990USD￡766GBP
- Report
- September 2020
- 2006 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- September 2020
- 2001 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- September 2020
- 2111 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- September 2020
- 2011 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- September 2020
- 2157 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- September 2020
- 2075 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- September 2020
- 2095 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- September 2020
- 2091 Pages
€3349EUR$3,850USD￡2,979GBP
- Report
- August 2020
- 80 Pages
From €2392EUR$2,750USD￡2,128GBP
- Drug Pipelines
- July 2020
- 351 Pages
From €6045EUR$6,950USD￡5,378GBP
- Drug Pipelines
- July 2020
- 200 Pages
From €6045EUR$6,950USD￡5,378GBP
- Report
- July 2020
- 100 Pages
From €3262EUR$3,750USD￡2,902GBP
- Drug Pipelines
- June 2020
- 55 Pages
From €1740EUR$2,000USD￡1,548GBP
- Drug Pipelines
- June 2020
- 380 Pages
From €1740EUR$2,000USD￡1,548GBP
- Drug Pipelines
- June 2020
- 327 Pages
From €1740EUR$2,000USD￡1,548GBP
- Drug Pipelines
- June 2020
- 2766 Pages
From €2174EUR$2,500USD￡1,935GBP
- Report
- June 2020
- 112 Pages
From €3697EUR$4,250USD￡3,289GBP
- Report
- June 2020
- 231 Pages
From €2700EUR$3,104USD￡2,402GBP
€3000EUR$3,449USD￡2,669GBP
- Report
- June 2020
- 212 Pages
From €2700EUR$3,104USD￡2,402GBP
€3000EUR$3,449USD￡2,669GBP
With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more
